MEDLINE INDUSTRIES, INC. MSC093001Recalls & reported problems
Medline Industries, Inc. · PROTECTANT,SKIN,MARATHON,LIQUID · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10884389109854), received between Apr 27, 2017 and Oct 21, 2025 — classified as 2 injuries.
The most frequently reported specific device problem is “Device Operates Differently Than Expected” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Operates Differently Than Expected1
- Patient-Device Incompatibility1
- Premature Separation1
- Separation Problem1
Patient problems
- Abrasion1
- Pain1
- Skin Inflammation/ Irritation1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 21, 2025Patient-Device Incompatibility; Separation Problem; Premature Separation; Patient-Device Incompatibility; Separation Problem; Premature Separation
ACCORDING TO THE FACILITY, THE MARATHON SKIN PROTECTANT WAS APPLIED TO AN OPEN AREA ON AN INFANT. WHEN THE NURSE WIPED THE INFANT'S BUTTOCKS, THE MARATHON BECAME DETACHED, AND THE INFANT EXPERIENCED FURTHER SKIN INJURY.
Patient problems: Abrasion; Skin Inflammation/ Irritation
MAUDE report 23350549 ↗InjuryApr 27, 2017Device Operates Differently Than Expected
PRODUCT IS MARATHON "LIQUID SKIN PROTECTANT" MANUFACTURED FOR MEDLINE INDUSTRIES, (B)(4). PRODUCT INFORMATION DATA SHEET CLAIMS THAT IT IS A "NON-CYTOTOXIC FAST-DRYING LIQUID BARRIER FILM FOR THE PROTECTION OF DAMAGED OR INTACT SKIN". IT CLAIMS IT IS "NO STING" AND IS INTENDED "TO PROTECT OR DAMAGED SKIN FROM THE EFFECTS OF MOISTURE, FRICTION (RUBBING), OR SHEAR (TEARING)." THIS DATA IS INCORRECT AND/OR MISLEADING, BECAUSE MY PATIENT EXPERIENCES EXCRUCIATING PAIN WHEN IT IS APPLIED TO THE DAMAGED SKIN OF HIS BUTTOCKS. HE IS PARAPLEGIC AND LIES ON HIS BUTTOCKS MOST OF THE TIME. DOSE OR AMOUNT: 0.5 G GRAMS. FREQUENCY: 4 TIMES A DAY. ROUTE: TOPICAL. THERAPY START DATE: (B)(6) 2017. THERAPY END DATE: (B)(6) 2017. DIAGNOSIS OR REASON FOR USE: DECUBITUS ULCER BUTTOCKS. EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED: YES.
Patient problems: Pain
MAUDE report 6533440 ↗
Other Bandage, liquid devices
- 3M™ Cavilon™ 50503m Company · Bandage, liquid4 reports
- 3M™ Cavilon™ 33453m Company · Bandage, liquid3 reports
- 3M™ Cavilon™ 33443m Company · Bandage, liquid2 reports
- 3M™ Cavilon™ 3343K3m Company · Bandage, liquid1 report
- Curity 6114Cardinal Health, Inc. · Bandage, liquid1 report
- 3M™ Cavilon™ 5051G3m Company · Bandage, liquid1 report
- 3M™ Cavilon™ 50503m Company · Bandage, liquid1 report
- 3M™ Cavilon™ 33423m Company · Bandage, liquid1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page